Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 7:18:100615.
doi: 10.1016/j.bbrep.2019.01.008. eCollection 2019 Jul.

NRLMF β: Beta-distribution-rescored neighborhood regularized logistic matrix factorization for improving the performance of drug-target interaction prediction

Affiliations

NRLMF β: Beta-distribution-rescored neighborhood regularized logistic matrix factorization for improving the performance of drug-target interaction prediction

Tomohiro Ban et al. Biochem Biophys Rep. .

Abstract

Techniques for predicting interactions between a drug and a target (protein) are useful for strategic drug repositioning. Neighborhood regularized logistic matrix factorization (NRLMF) is one of the state-of-the-art drug-target interaction prediction methods; it is based on a statistical model using the Bernoulli distribution. However, the prediction is not accurate when drug-target interaction pairs have less interaction information (e.g., the sum of the number of ligands for a target and the number of target proteins for a drug). This study aimed to address this issue by proposing NRLMF with beta distribution rescoring (NRLMFβ), which is an algorithm to improve the score of NRLMF. The score of NRLMFβ is equivalent to the value of the original NRLMF score when the concentration of the beta distribution becomes infinity. The beta distribution is known as a conjugative prior distribution of the Bernoulli distribution and can reflect the amount of interaction information to its shape based on Bayesian inference. Therefore, in NRLMFβ, the beta distribution was used for rescoring the NRLMF score. In the evaluation experiment, we measured the average values of area under the receiver operating characteristics and area under precision versus recall and the 95% confidence intervals. The performance of NRLMFβ was found to be better than that of NRLMF in the four types of benchmark datasets. Thus, we concluded that NRLMFβ improved the prediction accuracy of NRLMF. The source code is available at https://github.com/akiyamalab/NRLMFb.

Keywords: Bayesian inference; Bayesian optimization; Beta distribution; Drug–target interaction prediction; Neighborhood regularized logistic matrix factorization; Rescoring.

PubMed Disclaimer

Figures

Image 1
Graphical abstract
Figure 1
Figure 1
A plot showing the probability density function of the beta distribution and the improved value of the score. (a) Shows the change in the score when the original score s (assuming NRLMF score) is less than 0.5. s'1 is the concentration defined by a+b (assuming the new feature γ) value, and s'2 represents the score when the concentration value is small. Similarly, (b) shows the change in the score when the original score s is greater than 0.5.
Figure 2
Figure 2
Heatmaps of AUPR when hyperparameters η1,η2 are changed in each pair of cross-validation scenario (CVS) and dataset. The AUPR of each heatmap uses the average value of AUPR calculated for each CVS. However, hyperparameters without η1,η2 were fixed using different values for each pair of CVS and dataset. In addition, the frame in each figure is the search range of the hyperparameters η1,η2 defined in section 2.6.
Figure 3
Figure 3
Scatter plot of scores s,s' and feature quantities γ of NRLMF and NRLMFβ. The score was calculated using the leave-one-out method corresponding to CVS3 for the nuclear receptor dataset. The horizontal axis represents the score of each method, and the vertical axis represents the feature quantity we introduced.
Figure 4
Figure 4
Histogram for NRLMF and NRLMFβ scores s,s'. The score was calculated using the leave-one-out method corresponding to CVS3 for the nuclear receptor dataset. The horizontal axis represents the score of each method, and the vertical axis represents frequency (cutoff = 50).
Image 2

References

    1. Prasad Vinay, Mailankody Sham. Research and development spending to bring a single cancer drug to market and revenues after approval. JAMA Intern. Med. 2017;177:1569–1575. - PMC - PubMed
    1. Ashburn Ted T., Thor Karl B. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 2004;3:673–683. - PubMed
    1. Joong Sup Shim. Liu Jun O. Recent advances in drug repositioning for the discovery of new anticancer drugs. Int. J. Biol. Sci. 2014;10:654–663. - PMC - PubMed
    1. Li Jiao, Zheng Si, Chen Bin, Butte Atul J., Joshua Swamidass S., Lu Zhiyong. A survey of current trends in computational drug repositioning. Briefings Bioinf. 2016;17:2–12. - PMC - PubMed
    1. Shahreza Maryam Lotfi, Ghadiri Nasser, Rasoul Mousavi Sayed, Varshosaz Jaleh, James R. Green, A review of network-based approaches to drug repositioning. Briefings Bioinf. 2017:1–15. - PubMed

LinkOut - more resources